Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 120.40 |
| Open | 121.79 |
| Bid | 122.05 x 300 |
| Ask | 122.18 x 200 |
| Day's range | 119.43 - 122.34 |
| 52-week range | 62.55 - 170.47 |
| Volume | |
| Avg. volume | 3,935,358 |
| Market cap | 46.797B |
| Beta (5Y monthly) | 1.66 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -15.60 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 145.20 |
ZacksModerna (MRNA) Stock Before Q2 Earnings: To Buy or Not to Buy?
Investors will likely focus on updates on Moderna's (MRNA) pipeline, especially its late-stage pipeline candidates when it reports second-quarter earnings.
ZacksBeam Therapeutics (BEAM) Soars 7.9%: Is Further Upside Left in the Stock?
Beam Therapeutics (BEAM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Simply Wall St.Moderna Insiders Sell US$3.3m Of Stock, Possibly Signalling Caution
Many Moderna, Inc. ( NASDAQ:MRNA ) insiders ditched their stock over the past year, which may be of interest to the...
© 2024 Yahoo. All rights reserved.